Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia. - Niemann CU; Levin MD; Dubois J; Kersting S; Enggaard L; Veldhuis GJ; Mous R; Mellink CHM; Dobber JA; Poulsen CB; Frederiksen H; Janssens A; et al. (Blood, 2021)